Folic%25252525252525252525252525252520acid

# Folic Acid ## Overview Folic acid (Vitamin B9) is a water-soluble B-vitamin essential for DNA synthesis, repair, and erythropoiesis. Exogenous supplementation is required as it cannot be synthesized by the human body. ## Primary Indications * Treatment of folate deficiency anemia. * Prophylaxis of neural tube defects (NTDs) in pregnancy. * Prevention of folate deficiency in chronic hemolytic states (e.g., sickle cell disease) or dialysis. * Reduction of hematologic/GI toxicity associated with methotrexate therapy. ## Adult Dosing * **Folate Deficiency:** 1 mg daily. Severe cases may require up to 5 mg daily. * **Pregnancy (NTD Prevention):** 400–800 mcg daily, starting at least 1 month prior to conception and continuing through the first trimester. High-risk patients (history of NTD pregnancy): 4–5 mg daily. * **Methotrexate-induced toxicity:** 1–5 mg daily (or 5–10 mg weekly following methotrexate dose, depending on institutional protocols). ## Pediatric Dosing * **Folate Deficiency:** 0.5–1 mg daily. * **Maintenance (Chronic Hemolysis/Dialysis):** 0.1–1 mg daily, adjusted based on age and clinical condition. * **Infants:** 0.1 mg daily. ## Dose Adjustments * **Renal Impairment:** No specific adjustment required; however, patients on hemodialysis require supplementation to replace losses during dialysis (typically 1–5 mg daily). * **Hepatic Impairment:** Generally no adjustment required. ## Contraindications * Hypersensitivity to folic acid. * **Critical:** Pernicious anemia or other Vitamin B12 deficiency anemias. Folic acid can mask B12 deficiency symptoms (hematologic correction) while allowing irreversible neurologic damage to progress. ## Adverse Effects Generally well-tolerated. * **Rare:** Allergic reactions (rash, pruritus, erythema, bronchospasm). * **GI:** Nausea, abdominal distension, flatulence, bitter/altered taste. * **CNS:** Irritability, difficulty concentrating (reported rarely at very high doses). ## Key Drug Interactions * **Anticonvulsants (Phenytoin, Phenobarbital, Primidone):** Folic acid may decrease serum concentrations of these agents, potentially reducing seizure control. * **Methotrexate:** High doses of folic acid may interfere with the chemotherapeutic efficacy of methotrexate; use in this context requires careful timing and monitoring. * **Sulfonamides/Trimethoprim:** May interfere with folate metabolism. ## Monitoring * **Efficacy:** Hemoglobin, hematocrit, and reticulocyte counts. Serum folate and RBC folate levels (if indicated). * **Safety:** Monitor for signs of masked Vitamin B12 deficiency (neurological symptoms like paresthesia, gait instability) in patients receiving high-dose folate therapy. ## Clinical Pearls * Large doses of folic acid (>15 mg/day) may cause GI distress or sleep disturbances. * Folic acid is photosensitive; store in a light-resistant container. * Always rule out Vitamin B12 deficiency before initiating high-dose folic acid, as folic acid will correct the anemia but not the neurological sequelae of B12 deficiency. * Dosing for specific clinical protocols (e.g., oncology, rheumatology) should be verified against local guidelines, as they frequently vary. *** *Disclaimer: This information is for educational purposes only. Always verify current prescribing information, dosing guidelines, and patient-specific factors via institutional protocols, official package inserts, or clinical decision support tools before prescribing or administering medication.*